Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Per Jess

Showing results (31-40 of 45) with videos related to

Pageof 5
Sort By:
Immunopharmacology and Immunotoxicology|September 11, 2012
MUC4-specific CTLsCaroline B Madsen, Per Jess, Mikkel Harndahl, et al.
World Journal of Gastroenterology|March 14, 2013
Staging colorectal cancer with the TNM 7(th): the presumption of innocence when applying the M categoryGiacomo Puppa, Graeme Poston, Per Jess, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 1, 2016
Internal herniation after laparoscopic antecolic Roux-en-Y gastric bypass: a nationwide Danish study based on the Danish National Patient RegisterSara Danshøj Kristensen, Per Jess, Andrea Karen Floyd, et al.
Diseases of the Colon and Rectum|February 26, 2008
Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective studyPer Jess, Lene H Iversen, Mette B Nielsen, et al.
Biopreservation and Biobanking|July 18, 2015
Impact of in Vivo Ischemic Time on RNA Quality--Experiences from a Colon Cancer BiobankJesper Olsen, Lene T Kirkeby, Susanne Eiholm, et al.
Anticancer Research|April 12, 2015
High interleukin-6 mRNA expression is a predictor of relapse in colon cancerJesper Olsen, Lene T Kirkeby, Jørgen Olsen, et al.
Anticancer Research|February 13, 2010
Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancerBahir Aldulaymi, Ib J Christensen, György Sölétormos, et al.
Scandinavian Journal of Gastroenterology|April 11, 2012
Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's diseaseAlaa El-Hussuna, Jens Andersen, Thue Bisgaard, et al.
Anticancer Research|December 1, 2010
Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancerBahir Aldulaymi, Ib J Christensen, György Sölétormos, et al.
International Journal of Colorectal Disease|June 20, 2012
Gene expression profiles in stages II and III colon cancers: application of a 128-gene signatureMorten Thorsteinsson, Lene T Kirkeby, Raino Hansen, et al.
Pageof 5

Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Immunopharmacology and Immunotoxicology|September 11, 2012
MUC4-specific CTLsCaroline B Madsen, Per Jess, Mikkel Harndahl, et al.
World Journal of Gastroenterology|March 14, 2013
Staging colorectal cancer with the TNM 7(th): the presumption of innocence when applying the M categoryGiacomo Puppa, Graeme Poston, Per Jess, et al.
Surgery for Obesity and Related Diseases : Official Journal of the American Society for Bariatric Surgery|February 1, 2016
Internal herniation after laparoscopic antecolic Roux-en-Y gastric bypass: a nationwide Danish study based on the Danish National Patient RegisterSara Danshøj Kristensen, Per Jess, Andrea Karen Floyd, et al.
Diseases of the Colon and Rectum|February 26, 2008
Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective studyPer Jess, Lene H Iversen, Mette B Nielsen, et al.
Biopreservation and Biobanking|July 18, 2015
Impact of in Vivo Ischemic Time on RNA Quality--Experiences from a Colon Cancer BiobankJesper Olsen, Lene T Kirkeby, Susanne Eiholm, et al.
Anticancer Research|April 12, 2015
High interleukin-6 mRNA expression is a predictor of relapse in colon cancerJesper Olsen, Lene T Kirkeby, Jørgen Olsen, et al.
Anticancer Research|February 13, 2010
Changes in soluble CEA and TIMP-1 levels during adjuvant chemotherapy for stage III colon cancerBahir Aldulaymi, Ib J Christensen, György Sölétormos, et al.
Scandinavian Journal of Gastroenterology|April 11, 2012
Biologic treatment or immunomodulation is not associated with postoperative anastomotic complications in abdominal surgery for Crohn's diseaseAlaa El-Hussuna, Jens Andersen, Thue Bisgaard, et al.
Anticancer Research|December 1, 2010
Chemoradiation-induced changes in serum CEA and plasma TIMP-1 in patients with locally advanced rectal cancerBahir Aldulaymi, Ib J Christensen, György Sölétormos, et al.
International Journal of Colorectal Disease|June 20, 2012
Gene expression profiles in stages II and III colon cancers: application of a 128-gene signatureMorten Thorsteinsson, Lene T Kirkeby, Raino Hansen, et al.
Pageof 5